Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral micronized progesterone.

B de Lignières1

  • 1Department of Endocrinology and Reproductive Medicine, Hôpital Necker, Paris, France.

Clinical Therapeutics
|March 25, 1999
PubMed
Summary
This summary is machine-generated.

Oral micronized progesterone is a safer alternative to synthetic progestins for endometrial protection during estrogen therapy. It offers comparable bioavailability and efficacy with fewer metabolic and vascular side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women.

Climacteric : the journal of the International Menopause Society·2003
Same author

Effects of progestogens on the postmenopausal breast.

Climacteric : the journal of the International Menopause Society·2002
Same author

[Compliance with hormone replacement therapy in menopause: effect of an original education program. The COMET study].

Gynecologie, obstetrique & fertilite·2002
Same author

Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.

The Journal of reproductive medicine·2001
Same author

Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy.

Cephalalgia : an international journal of headache·2000
Same author

The place of combined oral contraceptives in contraception.

Cephalalgia : an international journal of headache·2000

Area of Science:

  • Endocrinology
  • Pharmacology
  • Gynecology

Background:

  • Unopposed estrogen therapy increases risks of endometrial hyperplasia and adenocarcinoma.
  • Synthetic progestins like norethisterone and medroxyprogesterone acetate have associated metabolic and vascular side effects.
  • Natural progesterone is biologically identical to endogenous hormones.

Purpose of the Study:

  • To review the rationale for using oral micronized progesterone over synthetic progestins for key indications.
  • To evaluate the safety and efficacy of oral micronized progesterone in endometrial protection.
  • To compare oral micronized progesterone with synthetic progestins in managing estrogen therapy side effects.

Main Methods:

  • Review of comparative studies and clinical trial data.

Related Experiment Videos

  • Analysis of pharmacokinetic data, including bioavailability and variability.
  • Examination of endometrial protection and side effect profiles.

    • Main Results:

    • Oral micronized progesterone demonstrates comparable bioavailability and inter/intra-individual variability to synthetic progestins.
    • It provides effective long-term endometrial protection with a favorable side effect profile, mainly mild drowsiness.
    • Comparative studies indicate synthetic progestins' side effects are minimized or eliminated with natural progesterone.

    Conclusions:

    • Oral micronized progesterone is recommended as a preferred option for opposing estrogen therapy in nonhysterectomized postmenopausal women.
    • It offers a safer alternative to synthetic progestins, mitigating risks of endometrial hyperplasia and adenocarcinoma.
    • The oral formulation circumvents inconvenience, providing a well-tolerated and effective therapeutic option.